Biomerica Stock Analysis

BMRA -  USA Stock  

USD 4.41  0.18  3.92%

The modest gains experienced by current holders of Biomerica could raise concerns from investors as the firm it trading at a share price of 4.41 on 94,232 in volume. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.28. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Biomerica partners.
Continue to Trending Equities.

Biomerica Stock Analysis 

 
Refresh
The Biomerica stock analysis report makes it easy to digest most publicly released information about Biomerica and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Biomerica Stock analysis module also helps to analyze the Biomerica price relationship with some important fundamental indicators such as market cap and management efficiency.

Biomerica Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.51. Biomerica had not issued any dividends in recent years. The entity had 1:2 split on the 7th of April 2016. Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Biomerica operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 66 people. For more info on Biomerica please contact Zackary Irani at 949 645 2111 or go to https://www.biomerica.com.

Biomerica Quarterly Cost of Revenue

3.88 MillionShare

Biomerica Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biomerica's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomerica or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Biomerica has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 7.32 M. Net Loss for the year was (6.12 M) with profit before overhead, payroll, taxes, and interest of 496.98 K.
Biomerica currently holds about 5 M in cash with (3.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Roughly 16.0% of the company shares are held by company insiders
Latest headline from www.marketbeat.com: Biomerica, Inc. Short Interest Up 18.0 percent in December - MarketBeat

Biomerica Upcoming and Recent Events

Earnings reports are used by Biomerica to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biomerica previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report13th of April 2022
Next Earnings Report26th of August 2022
Next Fiscal Quarter End28th of February 2022
Next Fiscal Year End26th of August 2022
Last Quarter Report30th of November 2021
Last Earning Announcement28th of February 2021

Biomerica Largest EPS Surprises

Earnings surprises can significantly impact Biomerica's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-01-12
2021-11-30-0.08-0.09-0.0112 
2019-10-15
2019-08-31-0.06-0.050.0116 
2019-01-14
2018-11-30-0.06-0.050.0116 
View All Earnings Estimates

Biomerica SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Biomerica prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Biomerica investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Biomerica specific information freely available to individual and institutional investors to make a timely investment decision.
16th of December 2021
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
View
10th of December 2021
Submission of Matters to a Vote of Security Holders
View
7th of December 2021
Other Events
View
30th of September 2021
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
View
24th of June 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View

Biomerica Thematic Classifications

In addition to having Biomerica stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Biomerica Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Biomerica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biomerica backward and forwards among themselves. Biomerica's institutional investor refers to the entity that pools money to purchase Biomerica's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Granahan Investment Management IncCommon SharesM4.6 M
Vanguard Group IncCommon Shares581.1 K2.6 M
Mg Investment Management LtdCommon Shares163.2 K816 K
Blackrock IncCommon Shares171.8 K774 K
Fore Capital LlcCommon Shares135 K608 K
Geode Capital Management LlcCommon Shares74.1 K333 K
Heritage Investors Management CorpCommon Shares69.3 K312 K
Susquehanna International Group LlpCall Options40.5 K182 K
Simplex Trading LlcPut Options35.7 K150 K
Note, although Biomerica's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biomerica Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 54.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerica's market, we take the total number of its shares issued and multiply it by Biomerica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Biomerica Profitablity

Biomerica's profitability indicators refer to fundamental financial ratios that showcase Biomerica's ability to generate income relative to its revenue or operating costs. If, let's say, Biomerica is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biomerica's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biomerica's profitability requires more research than a typical breakdown of Biomerica's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (83.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (84.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.84.
Last ReportedProjected for 2022
Return on Average Assets(0.48) (0.49) 
Return on Average Equity(0.62) (0.63) 
Return on Invested Capital(0.84) (0.86) 
Return on Sales(0.93) (0.95) 

Management Efficiency

The entity has return on total asset (ROA) of (28.11) % which means that it has lost $28.11 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (57.23) %, meaning that it created substantial loss on money invested by shareholders. Biomerica management efficiency ratios could be used to measure how well biomerica manages its routine affairs as well as how well it operates its assets and liabilities. As of January 21, 2022, Return on Average Assets is expected to decline to -0.49. In addition to that, Return on Average Equity is expected to decline to -0.63. Biomerica Tax Assets are projected to decrease significantly based on the last few years of reporting. The past year's Tax Assets were at 9,000. The current year Asset Turnover is expected to grow to 0.62, whereas Total Assets are forecasted to decline to about 11.5 M.
Last ReportedProjected for 2022
Book Value per Share 0.89  0.89 
Enterprise Value over EBIT(6.90) (7.44) 
Enterprise Value over EBITDA(6.69) (7.22) 
Price to Book Value 4.38  4.69 
Tangible Assets Book Value per Share 1.11  1.07 
Enterprise Value47.2 M46.7 M
Tangible Asset Value13.3 M11.2 M

Technical Drivers

As of the 21st of January, Biomerica shows the mean deviation of 3.45, and Risk Adjusted Performance of (0.032542). Biomerica technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Biomerica, which can be compared to its rivals. Please confirm Biomerica maximum drawdown, and the relationship between the information ratio and downside variance to decide if Biomerica is priced correctly, providing market reflects its regular price of 4.41 per share. Given that Biomerica has jensen alpha of (0.22), we suggest you to validate Biomerica's prevailing market performance to make sure the company can sustain itself at a future point.

Biomerica Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Biomerica price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average. View also all equity analysis or get more info about triple exponential moving average t3 overlap studies indicator.

Biomerica Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomerica insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomerica's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biomerica insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biomerica Predictive Daily Indicators

Biomerica intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biomerica stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biomerica Forecast Models

Biomerica time-series forecasting models is one of many Biomerica's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomerica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Biomerica Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biomerica stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biomerica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Biomerica. By using and applying Biomerica Stock analysis, traders can create a robust methodology for identifying Biomerica entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(0.88) (0.91) 
Gross Margin 0.0459  0.0471 
Profit Margin(0.93) (0.95) 
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Biomerica operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 66 people.

Current Biomerica Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biomerica analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biomerica analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
11.25Buy2Odds
Biomerica current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biomerica analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biomerica stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biomerica, talking to its executives and customers, or listening to Biomerica conference calls.
Biomerica Analyst Advice Details

Biomerica Stock Analysis Indicators

Biomerica stock analysis indicators help investors evaluate how Biomerica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biomerica shares will generate the highest return on investment. By understating and applying Biomerica stock analysis, traders can identify Biomerica position entry and exit signals to maximize returns.
Quick Ratio3.89
Fifty Two Week Low3.3000
Revenue Growth10.30%
Shares Short Prior Month1.18M
Average Daily Volume Last 10 Day102.8k
Average Daily Volume In Three Month246.4k
Shares Percent Shares Out6.38%
Gross Margins3.96%
Short Percent Of Float7.15%
Forward Price Earnings14.16
Float Shares10.49M
Fifty Two Week High8.1500
Enterprise Value To Ebitda-8.05
Fifty Day Average4.4504
Two Hundred Day Average4.3751
Enterprise Value To Revenue6.63
Continue to Trending Equities. Note that the Biomerica information on this page should be used as a complementary analysis to other Biomerica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Biomerica Stock analysis

When running Biomerica price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine Biomerica value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.